<DOC>
	<DOCNO>NCT00006030</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-rays damage tumor cell . Estrogen stimulate growth breast cancer cell . Hormone therapy use tamoxifen may fight breast cancer block uptake estrogen tumor cell . Combining radiation therapy tamoxifen surgery may kill tumor cell . It yet know treatment regimen effective stage I breast cancer . PURPOSE : Randomized phase III trial compare effectiveness four different treatment regimen treat woman stage I breast cancer .</brief_summary>
	<brief_title>Comparison Four Different Treatment Regimens Treating Women With Stage I Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Compare effectiveness wide local excision alone versus wide local excision follow radiotherapy without tamoxifen versus wide local excision plus tamoxifen woman stage I breast cancer . II . Assess local occurrence treat breast , regional recurrence , distant recurrence , death breast cancer , occurrence cancer opposite breast patient treat one regimen . OUTLINE : This randomize study . Patients randomize one four treatment arm . All patient undergo wide local excision tumor axillary node dissection . Arm I : Patients undergo surgery . Arm II : Patients undergo surgery follow 25-35 radiotherapy treatment . Arm III : Patients undergo surgery plus oral tamoxifen daily 5 year . Arm IV : Patients undergo surgery follow 25-35 radiotherapy treatment oral tamoxifen daily five year . Patients follow every 3 month 2 year , every 6 month thereafter . PROJECTED ACCRUAL : A total 1200 patient ( 300 per treatment arm ) accrue study .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Tamoxifen</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm unilateral stage I invasive breast cancer No 1 tumor great 2 cm Grade 1 tumor histological type OR No special type OR Mixed type allow No lymph node involvement No situ carcinoma ductal carcinoma situ microinvasion No vascular invasion No Paget 's disease nipple Well differentiate special type primary mammary carcinoma include : Tubular Tubular/cribriform Cribriform Papillary Mucoid No lobular , medullary , rare type mammary carcinoma include : Adenoid cystic Carcinoid Secretory Spindle cell Apocrine No distant metastases Hormone receptor status : Not specify PATIENT CHARACTERISTICS : Age : Under 70 Sex : Female Menopausal status : Not specify Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : Not pregnant nursing No systemic disease may preclude study No prior malignancy except adequately treat basal cell carcinoma skin carcinoma situ cervix PRIOR CONCURRENT THERAPY : No concurrent adjuvant systemic therapy</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2006</verification_date>
	<keyword>stage I breast cancer</keyword>
</DOC>